Quick Answer
Zymeworks Inc. reported Total Revenue of $105.97 million for the year ending 2025.
- Zymeworks Inc. showed an increase of +38.9% in Total Revenue from 2024 to 2025.
- This data is from Zymeworks Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $4.40 million | Q1 2022: $1.92 million | Q2 2022: $5.44 million | Q3 2022: $2.63 million | Q1 2023: $35.58 million | Q2 2023: $7.00 million | Q3 2023: $16.51 million | Q1 2024: $10.03 million | Q2 2024: $19.24 million | Q3 2024: $16.00 million | Q1 2025: $27.11 million | Q2 2025: $48.73 million | Q3 2025: $27.61 million.
- Over the full 6 years of available data (2020 to 2025), Zymeworks Inc.'s Total Revenue has grown by 172.0%.
- Historical annual values: Fiscal year 2025: $105.97 million | Fiscal year 2024: $76.30 million | Fiscal year 2023: $76.01 million | Fiscal year 2022: $412.48 million | Fiscal year 2021: $26.68 million | Fiscal year 2020: $38.95 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: